Evidence map›Paper›PMID 33335894›Full record

ReviewFrontiers in bioengineering and biotechnology2020

Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments.

Mohammed Moudjou, Johan Castille, Bruno Passet, Laetitia Herzog, Fabienne Reine, Jean-Luc Vilotte, Human Rezaei, Vincent Béringue, Angélique Igel-Egalon

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Tracking Prions by RT-QuIC: An Update.Sub-cellular biochemistry · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Mohammed MoudjouUniversité Paris Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Johan CastilleUniversité Paris Saclay, INRAE, AgroParisTech, GABI, Jouy-en-Josas, France.
Bruno PassetUniversité Paris Saclay, INRAE, AgroParisTech, GABI, Jouy-en-Josas, France.
Laetitia HerzogUniversité Paris Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Fabienne ReineUniversité Paris Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Jean-Luc VilotteUniversité Paris Saclay, INRAE, AgroParisTech, GABI, Jouy-en-Josas, France.
Human RezaeiUniversité Paris Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Vincent BéringueUniversité Paris Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Angélique Igel-EgalonUniversité Paris Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUniversité Paris-Saclay · FRAgroParisTech · FRSKF (France) · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prions are pathogenic infectious agents responsible for fatal, incurable neurodegenerative diseases in animals and humans. Prions are composed exclusively of an aggregated and misfolded form (PrP

Indexed as

amplificationdecontaminationPMCAprionsporadic CJDsurface

Identifiers

PMID33335894
PMCPMC7736614
OpenAlexW3109752952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.